The GENE chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the GENE chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The GENE stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View GENE Detailed Price Forecast - CNN Money||View GENE Detailed Summary - Google Finance|
|View GENE Detailed Summary - Yahoo! Finance||View GENE Stock Research & Analysis - Zacks.com|
|View GENE Trends & Analysis - Trade-Ideas||View GENE Major Holders - Barrons|
|View GENE Call Transcripts - NASDAQ||View GENE Breaking News & Analysis - Seeking Alpha|
|View GENE Annual Report - CompanySpotlight.com||View GENE OTC Short Report - OTCShortReport.com|
|View GENE Fundamentals - TradeKing||View GENE SEC Filings - Bar Chart|
|View Historical Prices for GENE - The WSJ||View Performance/Total Return for GENE - Morningstar|
|View the Analyst Estimates for GENE - MarketWatch||View the Earnings History for GENE - CNBC|
|View the GENE Earnings - StockMarketWatch||View GENE Buy or Sell Recommendations - MacroAxis|
|View the GENE Bullish Patterns - American Bulls||View GENE Short Pain Metrics - ShortPainBot.com|
|View GENE Stock Mentions - StockTwits||View GENE Stock Mentions - PennyStockTweets|
|View GENE Stock Mentions - Twitter||View GENE Investment Forum News - Investor Hub|
|View GENE Stock Mentions - Yahoo! Message Board||View GENE Stock Mentions - Seeking Alpha|
|View Insider Transactions for GENE - SECform4.com||View Insider Transactions for GENE - Insider Cow|
|View GENE Major Holdings Summary - CNBC||View Insider Disclosure for GENE - OTC Markets|
|View Insider Transactions for GENE - Yahoo! Finance||View Institutional Holdings for GENE - NASDAQ|
|View GENE Stock Insight & Charts - FinViz.com||View GENE Investment Charts - StockCharts.com|
|View GENE Stock Overview & Charts - BarChart||View GENE User Generated Charts - Trading View|
Genetic Technologies Limited Announces Research Collaboration with Two World-Renowned Medical Centres
Posted on Friday February 01, 2019
MELBOURNE, Australia, Feb. 01, 2019 -- Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “Company”), a diversified molecular diagnostics company is pleased to announce the.
Genetic Technologies Limited Provides End of Year Update on the Test Development Program
Posted on Friday December 21, 2018
Genetic Technologies Limited (ASX:GTG) (GENE) (“Company”), a diversified molecular diagnostics company embracing blockchain technologies across genomic testing platforms, provides today an update on its R&D program for the year. As announced to the market on 16th March 2018, Genetic Technologies Limited has embarked on a collaborative research program with academic research staff from the Centre for Epidemiology and Biostatistics at The University of Melbourne. Led by Professor John Hopper, the research is designed to broaden the applicability of the BREVAGenplus® breast cancer risk assessment test enabling its use in women with an extended family history of disease and will also increase the range of risk factors analysed.
Genetic Technologies Limited Announces New Biomedical Blockchain Joint Venture
Posted on Thursday December 20, 2018
MELBOURNE, Australia, Dec. 20, 2018 -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”), via its subsidiary Gene Ventures Pty Ltd, is pleased to announce that.
Today’s Research Reports on Stocks to Watch: Genetic Technologies and Innovate Biopharmaceuticals
Posted on Tuesday July 17, 2018
NEW YORK, NY / ACCESSWIRE / July 17, 2018 / Genetic Technologies saw big gains on news that its breast cancer and colorectal cancer risk assessment tests are on track. Shares of Innovate were headed in the opposite direction on news that the company has filed a securities registration statement amendment with the SEC to issue up to $175 million of new stock and to sell 14 million shares of existing stock. Innovate Biopharmaceuticals, Inc.